MJMan-Wen Jin

Man-Wen Jin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Man-Wen Jin has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Gui-Rong Li

    Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China

    4 shared publications
  • Kui-Hao Chen

    Department of Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China; Department of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

    4 shared publications
  • Hai-Ying Sun

    Department of Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China

    3 shared publications
  • Hui Liu

    Department of Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China; Department of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

    3 shared publications
  • Xiao-Hui Xu

    Department of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

    3 shared publications
  • Lei Yang

    Department of Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China; Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

    2 shared publications

Latest Publications

  • Distinctive property and pharmacology of voltage-gated sodium current in rat atrial vs ventricular myocytes

    by Kui-Hao Chen, Xiao-Hui Xu, Hai-Ying Sun, Xin-Ling Du, Hui Liu, Lei Yang, Guo-Sheng Xiao, Yan Wang, Man-Wen Jin, Gui-Rong Li


  • SKF-96365 strongly inhibits voltage-gated sodium current in rat ventricular myocytes

    by Kui-Hao Chen, Hui Liu, Lei Yang, Man-Wen Jin, Gui-Rong Li

    SKF-96365 (1-(beta-[3-(4-methoxy-phenyl) propoxy]-4-methoxyphenethyl)-1H-imidazole hydrochloride) is a general TRPC channel antagonist commonly used to characterize the potential functions of TRPC channels in cardiovascular system. Recent reports showed that SKF-96365 induced a reduction in cardiac conduction. The present study investigates whether the reduced cardiac conduction caused by SKF-96365 is related to the blockade of voltage-gated sodium current (I Na) in rat ventricular myocytes using the whole-cell patch voltage-clamp technique. It was found that SKF-96365 inhibited I Na in rat ventricular myocytes in a concentration-dependent manner. The compound (1 μM) negatively shifted the potential of I Na availability by 9.5 mV, increased the closed-state inactivation of I Na, and slowed the recovery of I Na from inactivation. The inhibition of cardiac I Na by SKF-96365 was use-dependent and frequency-dependent, and the IC50 was decreased from 1.36 μM at 0.5 Hz to 1.03, 0.81, 0.61, 0.56 μM at 1, 2, 5, 10 Hz, respectively. However, the selective TRPC3 antagonist Pyr3 decreased cardiac I Na by 8.5 % at 10 μM with a weak use and frequency dependence. These results demonstrate that the TRPC channel antagonist SKF-96365 strongly blocks cardiac I Na in use-dependent and frequency-dependent manners. Caution should be taken for interpreting the alteration of cardiac electrical activity when SKF-96365 is used in native cells as a TRPC antagonist.


  • TRPM7 channels regulate proliferation and adipogenesis in 3T3-L1 preadipocytes

    by Kui-Hao Chen, Xiao-Hui Xu, Yi Liu, Yan Hu, Man-Wen Jin, Gui-Rong Li

    Transient receptor potential melastatin-7 (TRPM7) channels are involved in many cellular physiological and pathological processes. The present study was designed to investigate the expression of TRPM7 channels and the potential role in regulating cell proliferation and adipogenesis in 3T3-L1 preadipocytes with approaches of whole-cell patch voltage-clamp, molecular biology, cell proliferation, adipogenesis, etc. We found that a TRPM7-like current was recorded with Mg(2+) -free pipette solution in 3T3-L1 preadipocytes, and the current was inhibited by intercellular free Mg(2+) . The TRPM7-like current was potentiated by acidic pH and inhibited by 2-aminoethoxydiphenyl borate (2-APB). RT-PCR, Western blot and immunocytochemistry revealed that gene and protein of TRPM7 channels were abundant in 3T3-L1 preadipocytes. Blockade of TRPM7 channels with 2-APB inhibited cell proliferation in 3T3-L1 cells. In addition, knockdown of TRPM7 with specific siRNA inhibited both proliferation and adipogenesis. The present study demonstrates for the first time that TRPM7 channels regulate cell cycle and adipogenesis of 3T3-L1 preadipocytes.


  • Open Access

    Allitridi Inhibits Multiple Cardiac Potassium Channels Expressed in HEK 293 Cells

    by Xiao-Hui Xu, Hai-Ying Sun, Yan-Hui Zhang, Wei Wu, Kui-Hao Chen, Yi Liu, Chun-Yu Deng, Xi-Yong Yu, Man-Wen Jin, Gui-Rong Li

    Allitridi (diallyl trisulfide) is an active compound (volatile oil) from garlic. The previous studies reported that allitridi had anti-arrhythmic effect. The potential ionic mechanisms are, however, not understood. The present study was designed to determine the effects of allitridi on cardiac potassium channels expressed in HEK 293 cells using a whole-cell patch voltage-clamp technique and mutagenesis. It was found that allitridi inhibited hKv4.3 channels (IC50 = 11.4 µM) by binding to the open channel, shifting availability potential to hyperpolarization, and accelerating closed-state inactivation of the channel. The hKv4.3 mutants T366A, T367A, V392A, and I395A showed a reduced response to allitridi with IC50s of 35.5 µM, 44.7 µM, 23.7 µM, and 42.4 µM. In addition, allitridi decreased hKv1.5, hERG, hKCNQ1/hKCNE1 channels stably expressed in HEK 293 cells with IC50s of 40.2 µM, 19.6 µM and 17.7 µM. However, it slightly inhibited hKir2.1 current (100 µM, inhibited by 9.8% at −120 mV). Our results demonstrate for the first time that allitridi preferably blocks hKv4.3 current by binding to the open channel at T366 and T367 of P-loop helix, and at V392 and I395 of S6 domain. It has a weak inhibition of hKv1.5, hERG, and hKCNQ1/hKCNE1 currents. These effects may account for its anti-arrhythmic effect observed in experimental animal models.


  • Functional ion channels and cell proliferation in 3T3-L1 preadipocytes

    by Xiao-Hua Zhang, Ying-Ying Zhang, Hai-Ying Sun, Man-Wen Jin, Gui-Rong Li

    Mouse 3T3-L1 preadipocytes are widely used for metabolic study of obesity; however, their cellular physiology is not fully understood. The present study investigates functional ion channels and their role in the regulation of cell proliferation using whole-cell patch voltage-clamp, RT-PCR, Western blot, and cell proliferation assay in undifferentiated 3T3-L1 preadipocytes. We found three types of ionic currents present in 3T3-L1 preadipocytes, including an inwardly-rectifying K + current (I Kir, recorded in 15% of cells) inhibited by Ba 2+, a Ca 2+-activated intermediate K + current (IK Ca, recorded in 44% of cells) inhibited by clotrimazole (or TRAM-34) as well as a chloride current (I Cl) inhibited by 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS) in 12% of cells, which can be activated in all cells with hypotonic (0.8T) insult, implicating a volume-sensitive I Cl (I Cl.vol). RT-PCR and Western blot analysis revealed the expression of KCa3.1 (for IK Ca), Kir2.1 (for I Kir), and Clcn3 (for I Cl.vol). Blockade of IK Ca with TRAM-34 or I Cl.vol with DIDS inhibited cell proliferation in a concentration-dependent manner. Knockdown of KCa3.1 or Clcn3 with specific siRNAs also suppressed cell proliferation. Flow cytometry analysis showed that blockade or silencing of KCa3.1 or Clcn3 channels with corresponding blockers or siRNAs caused an accumulation of cells at the G0/G1 phase. These results demonstrate that three functional ion channel currents, I KCa, I Cl.vol, and I Kir, are heterogeneously present in 3T3-L1 preadipocytes. I KCa and I Cl.vol participate in the regulation of cell proliferation. © 2011 Wiley Periodicals, Inc.link_to_subscribed_fulltex


    • 1 April 2004
      • Vol. 39  (4) , 250-3

    [Effects of hydrocortisone sodium succinate on sodium current in human and guinea pig cardiac myocytes].

    by Zhuang-Li Hu, Hui Liu, Yan Hu, De-Yong Zhang, Zong-Quan Sun, Man-Wen Jin

    To study the effects of hydrocortisone sodium succinate on sodium current in human atrial myocytes and in guinea pig ventricular myocytes. Single cardiac myocytes were isolated by enzyme. The effects of hydrocortisone sodium succinate on sodium current (INa) were assessed by applying whole-cell patch clamp techniques. Hydrocortisone sodium succinate (1, 3, 10 micromol x L(-1)) was shown to inhibit INa of both human atrial myocytes and guinea pig ventricular myocytes in concentration dependent manner and the IC50 were 6.97 and 8.74 micromol x L(-1), respectively. The inhibition effects acted quickly (1-3 min) and the maximal activating voltage of INa was not changed in both human and guinea pig cardiac myocytes. Hydrocortisone sodium succinate can exhibit inhibitory effects on INa in both human and guinea pig cardiac myocytes, and its inhibitory effects act rapidly, which are not consistent with genomic effects, so there may be nongenomic effects.